Pharmacologic prevention of venous thromboembolism in obese patients
- 21 November 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Thrombosis and Thrombolysis
- Vol. 36 (3), 247-257
- https://doi.org/10.1007/s11239-012-0844-1
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Impact of Obesity on Drug Metabolism and Elimination in Adults and ChildrenClinical Pharmacokinetics, 2012
- Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest, 2012
- VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest, 2012
- Prevention of VTE in Nonorthopedic Surgical Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest, 2012
- Oral Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest, 2012
- Parenteral Anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest, 2012
- Angiogenesis and development of adipose tissueMolecular and Cellular Endocrinology, 2010
- Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patientsThrombosis Research, 2010
- Effect of Obesity on the Pharmacokinetics of Drugs in HumansClinical Pharmacokinetics, 2010
- Cardiac Remodeling in ObesityPhysiological Reviews, 2008